Vilquin P., Donini C., Villedieu M., Grisard E., Corbo L., Bachelot T., Vendrell J. and Cohen P.A. miR-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Breast Cancer Res. (In press)
Chapat C, Corbo L. Novel roles of the CCR4-NOT complex. Wiley Interdiscip Rev RNA. Nov 2014
Katia Bouchekioua-Bouzaghou, Coralie Poulard, Juliette Rambaud, Emilie Lavergne, Nader Hussein,, Marc Billaud, Thomas Bachelot, Sylvie Chabaud, Sylvie Mader,Guila Dayan, Isabelle Treilleux ,Laura Corbo and Muriel Le Romancer. LKB1 when associated with methylated ERa is a marker of bad prognosis in breast cancer. Int J Cancer, Sep 2014.
Nguyen NT, Vendrell JA, Poulard C, Gyorffy B, Goddard-Léon S, Bièche I, Corbo L, Treilleux I, Le Romancer M, Cohen PA. A functional interplay between ZNF217 and Estrogen receptor alpha exists in luminal breast cancers. Mol. Oncol. (2014)
Fabrice André , Thomas Bachelot, Frederic Commo, Mario Campone, Monica Arnedos, Véronique Dieras, Magali Lacroix-Triki, Ludovic Lacroix, Pascale Cohen, David Gentien, Jose Adélaide, Florence Dalenc, Anthony Goncalves, Christelle Levy, Jean-Marc Ferrero, Jacques Bonneterre, Claudia Lefeuvre, Marta Jimenez,Thomas Filleron, Hervé Bonnefoi. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial.Lancet Oncology 2014
Coralie Poulard, Juliette Rambaud, Nader Hussein, Laura Corbo and Muriel Le Romancer. JMJD6 regulates ERα methylation on arginine. Plos One, Feb 2014
Poulard C, Rambaud J, Le Romancer M, Corbo L. Proximity ligation assay to detect and localize the interactions of ERα with PI3-K and Src in breast cancer cells and tumor samples. Methods Mol Biol. 2014
Guen VJ, Gamble C, Flajolet M, Unger S, Thollet A, Ferandin Y, Superti-Furga A, Cohen PA, Meijer L, Colas. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome. P. Proc Natl Acad Sci U S A. 2013
Vilquin P., Villedieu M., Grisard E., Ben larbi S., Ghayad S., Heudel P., Bachelot T., Corbo L., Treilleux I., Vendrell J. and CohenPA. Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor. Int J of cancer. (2013)
E. Prestat, S. Rodrigues de Morais, J. Vendrell, A. Thollet, C. Gautier, P. Cohen and A. Aussem. Learning the local Bayesian network structure around the ZNF217 oncogene in breast tumours.Computers in Biology and Medicine (2013)
Chapat C, Kolytcheff C, Le Romancer M, Auboeuf D, De La Grange P, Chettab K, Sentis S and Corbo L.hCAF1 regulates interferon signalling by targeting STAT1. (2013). The EMBO Journal. 2013 Feb 5. doi: 10.1038
Poulard C, Treilleux I, Lavergne E, Bouchekioua-Bouzaghou K, Goddard-Leon S, Chabaud S, Trédan O, Corbo L and Le Romancer M. "Activation of rapid oestrogen signalling in aggressive human breast cancers". EMBO Mol Med. 2012 Oct 15
Vendrell JA, Thollet A.,Nguyen NT, Ghayad SE., Vinot S., Biéche I., Grisard E., Josserand V., Coll JL., Roux P., Corbo L., Treilleux I., Rimokh R., and Cohen PA. "ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion". Cancer Research. 2012 Jul 15.
Romancer, M., Poulard, C., Sentis, S., and Corbo, L. (2012). Post-translational Modifications of ER Alpha in Rapid Estrogen Action in Advances in Rapid Sex-Steroid Action. G. Castoria and A. Migliaccio, eds. Springer New York, pp. 79-93.
Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L. “Cracking the EstrogenReceptor's Posttranslational Code in Breast Tumors” Endocrine Reviews. (2011) 32(5):597-622.
Thollet A, Vendrell JA, Payen L, Ghayad SE, Ben Larbi S, Grisard E, Collins C, Villedieu M, Cohen PA.ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells. Molecular Cancer. (2010) 9:291.
Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathway. Int. J. of Cancer (2010) 126, 546-562.
Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavailles V Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab (2010) 21:181-189
Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S and Corbo L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell (2008) 31:212-221.
Robin-Lespinasse Y, S Sentis, C Kolytcheff, M-C Rostan Corbo L and M Le Romancer hCAF1, a new regulator of PRMT1-dependent arginine méthylation, J. Cell Sci (2007) 15;120:638-47
Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, Cohen PA. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen-resistance in breast cancer cells. Oncogene (2007) 26, 4656-67.